In particular, NOTCH2 H107P and BCR T1127S variants were almost clonal (i.e., present in all somatic cells), whereas EPHA7 L564F and MTOR S920F were subclonal alterations, present in around 35% of cancer cells. This evidence concerns the gene NOTCH2 and cancer.